Snapshot from Jun 10, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Senseonics highlights Eversense 365 at ADA
Business analyst event

Senseonics highlights Eversense 365 at ADA

Analysis based on 6 articles · First reported Jun 01, 2026 · Last updated Jun 01, 2026

Sentiment
20
Attention
2
Articles
6
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The events are expected to positively impact Senseonics Holdings by showcasing its Eversense 365 platform and providing updates on commercial progress and clinical data. This could lead to increased investor confidence and potential growth in the medical technology market.

medical technology healthcare
Event Summary

Senseonics Holdings is hosting two key events during the 86th Scientific Sessions of the American Diabetes Association (ADA) from June 5-8, 2026, in New Orleans, Louisiana. The first is an analyst event on June 6, 2026, where Senseonics Holdings will provide a comprehensive update on Eversense 365 commercial progress, including its European launch, integration with the Sequel Twist Pump, pipeline development (Gemini and Freedom programs), and clinical data. Dr. David T. Ahn will share his experience with Eversense 365. The second event is an oral presentation by Francine Ratner Kaufman, Chief Medical Officer at Senseonics Holdings, on June 6, 2026, titled 'Real-World Evaluation of the Implantable One-Year Eversense 365 CGM System,' which will explore new data on Eversense 365 performance and impact in the United States.

Key Actions
85 Senseonics Holdings hosted analyst event
70 Francine Ratner Kaufman hosted oral presentation
50 David T. Ahn discussed experience
Entities Involved
stock
Senseonics Holdings
Senseonics Holdings, Inc. is hosting an analyst event and an oral presentation at the ADA Scientific Sessions to discuss its Eversense 365 platform, which could positively impact its market position and investor confidence.
Importance 100 Sentiment 20
oth
Eversense
Eversense 365 is the primary product being highlighted by Senseonics Holdings, Inc. at the ADA Scientific Sessions, with discussions on its commercial progress, pipeline development, and clinical data.
Importance 90 Sentiment 20
per
Francine Ratner Kaufman
Francine Ratner Kaufman, Chief Medical Officer at Senseonics Holdings, Inc., will be hosting an oral presentation on the Eversense 365 system, highlighting its real-world performance and impact.
Importance 70 Sentiment 10
ngo
American Diabetes Association
The American Diabetes Association is hosting its 86th Scientific Sessions, providing a platform for Senseonics Holdings, Inc. to present its Eversense 365 system and engage with analysts and medical professionals.
Importance 60 Sentiment 0
per
David T. Ahn
Dr. David T. Ahn will discuss his experience with Eversense 365, including the insertion procedure and patient satisfaction, at the Senseonics Holdings, Inc. analyst event.
Importance 50 Sentiment 10
oth
Sequel Twist Pump
The Sequel Twist Pump is mentioned in the context of its integration with the Eversense 365 platform, indicating potential for broader market adoption and functionality.
Importance 30 Sentiment 10
loc
Europe
The European launch of Eversense 365 is a key commercial progress update to be discussed at the Senseonics Holdings, Inc. analyst event, indicating market expansion.
Importance 20 Sentiment 0
cnt
United States
The oral presentation will explore new data evaluating Eversense 365 performance and impact in open and closed loop systems in the United States.
Importance 20 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.